Item 1.01 Entry into a Material Definitive Agreement

On May 26, 2020, R1 RCM Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Barclays Capital Inc. and J.P. Morgan Securities LLC, as the representatives of the several underwriters listed on Schedule 1 thereto (the "Underwriters"), and the selling stockholders listed on Schedule 2 thereto (the "Selling Stockholders") with respect to an underwritten offering of 15,000,000 shares (the "Shares") of the Company's common stock, par value $0.01 per share (the "Common Stock"), at a public offering price of $22.50 per share, to be sold by the Selling Stockholders. Under the terms of the Underwriting Agreement, one of the Selling Stockholders granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 2,250,000 shares of Common Stock (the "Option Shares") from it, and the Underwriters exercised such option to purchase the Option Shares on May 28, 2021. The closing of the offering and delivery of the Shares took place on June 1, 2021. The closing of the offering and delivery of the Option Shares is expected to occur on June 2, 2021, subject to customary closing conditions. The Company will not receive any proceeds from the sale of the Shares or the Option Shares.

The offering was made pursuant to an automatically effective Registration Statement on Form S-3ASR (File No. 333-256465) filed with the Securities and Exchange Commission (the "SEC") on May 25, 2021, including a related base prospectus. A prospectus supplement relating to the offering has been filed with the SEC.

The foregoing summary of the Underwriting Agreement is qualified in its entirety by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1, and incorporated by reference herein.

Item 3.02 Unregistered Sales of Equity Securities

On May 27, 2020, the Company issued 14,500,000 shares of common stock to a warrant holder upon the cashless exercise of a warrant to purchase 16,912,646 shares of common stock at an exercise price of $3.50 per share based upon a market value of $24.54 per share as determined under the terms of the warrant.

On May 28, 2020, the Company issued 2,250,000 shares of common stock to a warrant holder upon the cashless exercise of a warrant to purchase 2,622,499 shares of common stock at an exercise price of $3.50 per share based upon a market value of $24.64 per share as determined under the terms of the warrant.

The foregoing securities were issued in reliance upon the exemption from registration pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits






 Exhibit
 Number          Description

      1.1          Underwriting Agreement, dated as of May 26, 2021, by and among the
                 Company, the Selling Stockholders and Barclays Capital Inc. and J.P.
                 Morgan Securities LLC, as representatives of the Underwriters.

      5.1          Opinion of Kirkland & Ellis LLP.

     23.1          Consent of Kirkland & Ellis LLP (included in Exhibit 5.1).

     99.1          Information relating to Part II, Item 14. "Other Expenses of
                 Issuance and Distribution" of the Company's Registration Statement
                 on Form S-3ASR (File No. 333-256465).

      104        Cover Page Interactive Data File - the cover page iXBRL tags are
                 embedded within the Inline XBRL document.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses